These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 1788329)

  • 1. Effects of serotonergic compounds on associative learning.
    Meneses A; Hong E
    Proc West Pharmacol Soc; 1991; 34():461-4. PubMed ID: 1788329
    [No Abstract]   [Full Text] [Related]  

  • 2. The activation of serotonergic 5-HT1A presynaptic receptors or an enhancement of 5-HT postsynaptic activity increase learning.
    Hong E; Meneses A
    Proc West Pharmacol Soc; 1995; 38():85-6. PubMed ID: 7480032
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of serotonergic drugs on negative contrast in consummatory behavior.
    Flaherty CF; Grigson PS; Demetrikopoulos MK; Weaver MS; Krauss KL; Rowan GA
    Pharmacol Biochem Behav; 1990 Aug; 36(4):799-806. PubMed ID: 2145592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ritanserin, a selective and specific S2-serotonergic antagonist, on portal pressure and splanchnic hemodynamics in portal hypertensive rats.
    Nevens F; Pizcueta MP; Fernández M; Bosch J; Rodés J
    Hepatology; 1991 Dec; 14(6):1174-8. PubMed ID: 1959867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonergic modulation of footshock induced aggression in paired rats.
    Datla KP; Mitra SK; Bhattacharya SK
    Indian J Exp Biol; 1991 Jul; 29(7):631-5. PubMed ID: 1839019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressant-like effects of 5-hydroxytryptamine1A receptor agonists on operant responding under a response duration differentiation schedule.
    Kinney GG; Griffith JC; Hudzik TJ
    Behav Pharmacol; 1998 Jul; 9(4):309-18. PubMed ID: 10065919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anxiolytic activity of a novel potent serotonin 5-HT2C receptor antagonist FR260010: a comparison with diazepam and buspirone.
    Harada K; Aota M; Inoue T; Matsuda R; Mihara T; Yamaji T; Ishibashi K; Matsuoka N
    Eur J Pharmacol; 2006 Dec; 553(1-3):171-84. PubMed ID: 17074317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indorenate produces antidepressant-like actions in the rat forced swimming test via 5-HT1A receptors.
    Martínez-Mota L; Estrada-Camarena E; López-Rubalcava C
    Psychopharmacology (Berl); 2002 Dec; 165(1):60-6. PubMed ID: 12474119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential vascular alpha1-adrenoceptor blocking properties of an array of 5-HT receptor ligands in the rat.
    Centurión D; Mehotra S; Sánchez-López A; Gupta S; MaassenVanDenBrink A; Villalón CM
    Eur J Pharmacol; 2006 Mar; 535(1-3):234-42. PubMed ID: 16545797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of buspirone and related compounds on suppressed operant responding in rats.
    Sanger DJ
    J Pharmacol Exp Ther; 1990 Aug; 254(2):420-6. PubMed ID: 1974634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-HT2-receptor antagonists: alpha 1- vs. 5-HT2-receptor blocking properties in blood vessels.
    Cohen ML; Schenck KW; Kurz KD
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S25-9. PubMed ID: 2459510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TR2515, a quinazolinedione derivative blocks microiontophoretic induced inhibition of raphe cell firing by serotonergic drugs.
    Galindo-Morales JA; Hong E; Barragán LA
    Proc West Pharmacol Soc; 1985; 28():177-9. PubMed ID: 4070245
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT2A/2C antagonist anxiolytics. I. Antipunishment effects in the pigeon.
    Kleven MS; Koek W
    J Pharmacol Exp Ther; 1996 Feb; 276(2):388-97. PubMed ID: 8632301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective 5-hydroxytryptamine2 antagonists have antidepressant-like effects on differential-reinforcement-of-low-rate 72-second schedule.
    Marek GJ; Li AA; Seiden LS
    J Pharmacol Exp Ther; 1989 Jul; 250(1):52-9. PubMed ID: 2746510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diphenyl diselenide exerts anxiolytic-like effect in Wistar rats: putative roles of GABAA and 5HT receptors.
    Ghisleni G; Kazlauckas V; Both FL; Pagnussat N; Mioranzza S; Rocha JB; Souza DO; Porciúncula LO
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1508-15. PubMed ID: 18579279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling of latent inhibition in rats by activation of the central serotoninergic system.
    Loskutova LV; Luk'yanenko FYa ; Il'yuchenok RYu
    Neurosci Behav Physiol; 1990; 20(6):541-2. PubMed ID: 2096327
    [No Abstract]   [Full Text] [Related]  

  • 17. On the role of serotonin in drug reward: studies with the place conditioning procedure.
    Spyraki C; Nomikos G
    Pol J Pharmacol Pharm; 1991; 43(3):221-9. PubMed ID: 1961695
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of learning schedules on operant behavior in toluene inhaled rats (author's transl)].
    Shigeta S; Aikawa H; Misawa T; Yokoyama M
    Nihon Eiseigaku Zasshi; 1981 Jun; 36(2):541-9. PubMed ID: 7311099
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention of serotonin abortion by serotonin antagonists in rats.
    Sadovsky E; Weinstein D; Pfeifer Y; Polishuk WZ; Sulman FG
    Arch Int Pharmacodyn Ther; 1973 Oct; 205(2):305-16. PubMed ID: 4148832
    [No Abstract]   [Full Text] [Related]  

  • 20. Involvement of the serotoninergic system in the mechanism of action of ultralow dose antibodies to S-100 protein.
    Kheifets IA; Dugina YL; Voronina TA; Molodavkin GM; Martyushev-Poklad AV; Sergeeva SA; Epstein OI
    Bull Exp Biol Med; 2007 May; 143(5):598-600. PubMed ID: 18239778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.